1
|
D'Antonio F, Eltaweel N, D'Amico A, Khalil A. Role of cerclage in twin and singleton pregnancy: evidence from systematic review and meta-analysis. Ultrasound Obstet Gynecol 2024; 63:567-569. [PMID: 37983619 DOI: 10.1002/uog.27539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/24/2023] [Revised: 11/08/2023] [Accepted: 11/13/2023] [Indexed: 11/22/2023]
Affiliation(s)
- F D'Antonio
- Center for Fetal Care and High-Risk Pregnancy, University of Chieti, Chieti, Italy
| | - N Eltaweel
- Division of Biomedical Science, Warwick Medical School, University of Warwick, University Hospital of Coventry and Warwickshire, Coventry, UK
| | - A D'Amico
- Center for Fetal Care and High-Risk Pregnancy, University of Chieti, Chieti, Italy
| | - A Khalil
- Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, University of London, London, UK
- Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK
- Twins Trust Centre for Research and Clinical Excellence, St George's Hospital, London, UK
- Fetal Medicine Unit, Liverpool Women's Hospital, University of Liverpool, Liverpool, UK
| |
Collapse
|
2
|
Lian J, Walker RG, D'Amico A, Vujic A, Mills MJ, Messemer KA, Mendello KR, Goldstein JM, Leacock KA, Epp S, Stimpfl EV, Thompson TB, Wagers AJ, Lee RT. Functional substitutions of amino acids that differ between GDF11 and GDF8 impact skeletal development and skeletal muscle. Life Sci Alliance 2023; 6:e202201662. [PMID: 36631218 PMCID: PMC9834663 DOI: 10.26508/lsa.202201662] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Revised: 12/11/2022] [Accepted: 12/12/2022] [Indexed: 01/13/2023] Open
Abstract
Growth differentiation factor 11 (GDF11) and GDF8 (MSTN) are closely related TGF-β family proteins that interact with nearly identical signaling receptors and antagonists. However, GDF11 appears to activate SMAD2/3 more potently than GDF8 in vitro and in vivo. The ligands possess divergent structural properties, whereby substituting unique GDF11 amino acids into GDF8 enhanced the activity of the resulting chimeric GDF8. We investigated potentially distinct endogenous activities of GDF11 and GDF8 in vivo by genetically modifying their mature signaling domains. Full recoding of GDF8 to that of GDF11 yielded mice lacking GDF8, with GDF11 levels ∼50-fold higher than normal, and exhibiting modestly decreased muscle mass, with no apparent negative impacts on health or survival. Substitution of two specific amino acids in the fingertip region of GDF11 with the corresponding GDF8 residues resulted in prenatal axial skeletal transformations, consistent with Gdf11-deficient mice, without apparent perturbation of skeletal or cardiac muscle development or homeostasis. These experiments uncover distinctive features between the GDF11 and GDF8 mature domains in vivo and identify a specific requirement for GDF11 in early-stage skeletal development.
Collapse
Affiliation(s)
- John Lian
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| | - Ryan G Walker
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| | - Andrea D'Amico
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| | - Ana Vujic
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| | - Melanie J Mills
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| | - Kathleen A Messemer
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| | - Kourtney R Mendello
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| | - Jill M Goldstein
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| | - Krystynne A Leacock
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| | - Soraya Epp
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| | - Emma V Stimpfl
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| | - Thomas B Thompson
- Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati, Cincinnati, OH, USA
| | - Amy J Wagers
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
- Joslin Diabetes Center, Boston, MA, USA
- Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA
| | - Richard T Lee
- Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA
| |
Collapse
|
3
|
Ricci G, Maggi L, D'Amico A, Fiorillo C, Schirinzi E, Pini A, Pegoraro E, Bertini E, Bernascono P, Lattanzi G, Gerfo AL, Siciliano G. P.147 Deflazacort treatment in LMNA-related congenital muscular dystrophy: an ongoing Italian cohort pilot study. Neuromuscul Disord 2022. [DOI: 10.1016/j.nmd.2022.07.275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
4
|
Adorisio R, Cantarutti N, Cicenia M, D'Anna C, Bellettini E, Mencarelli E, D'Amico A, Kirk R, Amodeo A. Cardiac Atrophy and ACE Inhibitors in Duchenne Cardiomyopathy: 10 Years is the Right Age to Start Therapy? J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.1263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
5
|
Gouda G, D'Amico A, Abd Allah Eni A, Fayed M, Abdulaal A, Sabra M, Bogaerts M. Optimized Cement Slurry Design for Controlling Water Influx in a Gulf of Suez Egypt Salt Dome. Day 1 Mon, February 21, 2022 2022. [DOI: 10.2523/iptc-21955-ms] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
Abstract
Abstract
The Belayim Marine field, in the Gulf of Suez Egypt, presents many challenges to drilling operators. The most challenging section of the well is the 900-m, 16-in openhole containing a 13 5/8-in casing interval. The main risks in this section are the highly reactive salt layers in combination with high potential saltwater flow zones.
This interval is frequently drilled with a heavy 2.0-sg OBM to avoid saltwater influx during the drilling operations. Due to the mobility of the salt and unstable shale formations, the casing is run without centralizers to minimize the risks of not getting the casing to the desired section depth. Initially the interval was cemented using a 2.16-sg cement system with extended thickening time, both having the same 2.16-sg density. An external casing packer is used as an additional barrier in the event the cement placement does not achieve zonal isolation across the casing due to poor standoff.
After saltwater flow was observed at surface following the installation of the BOP, a detailed review of the casing and cementing design was performed to obtain a more robust procedure to avoid similar events in the future. Cement placement, operation design, and slurry properties were reviewed and optimized. The optimization was performed using details obtained from proprietary simulators as well as by optimizing the slurry properties in the laboratory. The cement operation design called for a single slurry scheme with very critical parameters, ensuring the cement will remain in the liquid phase to maintain applied pressure on the flow zone formations until the BOP is secured. The slurry design itself was revised and optimized in the laboratory providing right angle set along with good transition time to avoid any saltwater influx from formation fluids.
The optimized cement design and slurry properties have met all challenges. Furthermore, the new cement design in conjunction with the external casing packer succeeded in stopping the water flow influx and no similar events have occurred since the new cement operations design began being used in the field.
Collapse
|
6
|
Soda C, Squintani G, Teli M, Marchesini N, Ricci U, D'Amico A, Basaldella F, Concon E, Tramontano V, Romito S, Tommasi N, Pinna G, Sala F. Degenerative cervical myelopathy: Neuroradiological, neurophysiological and clinical correlations in 27 consecutive cases. Brain and Spine 2022; 2:100909. [PMID: 36248151 PMCID: PMC9560670 DOI: 10.1016/j.bas.2022.100909] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/10/2022] [Revised: 06/04/2022] [Accepted: 06/24/2022] [Indexed: 01/11/2023]
Abstract
New insight into prognostic factors for recovery of clinical function following posterior decompression for degenerative cervical myelopathy. An increase of IOM amplitude of at least 50% coupled with preoperative T2-only and diffuse T2 signal changes on MRI is a positive prognostic factors for clinical improvement 6 months after surgery. Clinical improvement at 6 months follow-up can be expected in patients with T1 hypo intensity if a diffuse border of the lesion on T2 images is present.
Collapse
|
7
|
Panicucci C, Baratto S, Lizzia R, Tonin P, D'Amico A, Tasca G, Traverso M, Fiorillo C, Previtali S, Pegoraro E, Bruno C. LGMD. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
8
|
Adorisio R, Cantarutti N, D'Amario D, Grandinetti M, D'Amico A, Perri G, Filippelli S, Drago F, Amodeo A. Long-Term Outcome of LVAD in Duchenne Population with End Stage Cardiomyopathy. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
9
|
Buca D, Di Mascio D, Rizzo G, Giancotti A, D'Amico A, Leombroni M, Makatsarya A, Familiari A, Liberati M, Nappi L, Flacco ME, Manzoli L, Salomon LJ, Scambia G, D'Antonio F. Outcome of fetuses with congenital cytomegalovirus infection and normal ultrasound at diagnosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2021; 57:551-559. [PMID: 33030767 DOI: 10.1002/uog.23143] [Citation(s) in RCA: 35] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2020] [Revised: 08/23/2020] [Accepted: 09/25/2020] [Indexed: 02/05/2023]
Abstract
OBJECTIVE To report the outcome of fetuses with congenital cytomegalovirus (CMV) infection and normal ultrasound at the time of diagnosis, and to evaluate the rate of an additional anomaly detected only on magnetic resonance imaging (MRI). METHODS Medline, EMBASE, CINAHL and Cochrane databases were searched for studies reporting on the outcome of fetuses with congenital CMV infection. Inclusion criteria were fetuses with confirmed CMV infection and normal ultrasound assessment at the time of the initial evaluation. The outcomes observed were an anomaly detected on a follow-up ultrasound scan, an anomaly detected on prenatal MRI but missed on ultrasound, an anomaly detected on postnatal assessment but missed prenatally, perinatal mortality, symptomatic infection at birth, neurodevelopmental outcome and hearing and visual deficits. Neurodevelopmental outcome was assessed only in cases of isolated CMV infection confirmed at birth. Subgroup analysis was performed according to the trimester in which maternal infection occurred. Random-effects meta-analysis of proportions was used to analyze the data. RESULTS Twenty-six studies were included, comprising 2603 fetuses with congenital CMV infection, of which 1178 (45.3%) had normal ultrasound at the time of diagnosis and were included in the analysis. The overall rate of an associated central nervous system (CNS) anomaly detected on a follow-up ultrasound scan was 4.4% (95% CI, 1.4-8.8%) (32/523; 15 studies), while the rates of those detected exclusively on prenatal MRI or on postnatal imaging were 5.8% (95% CI, 1.9-11.5%) (19/357; 11 studies) and 3.2% (95% CI, 0.3-9.0%) (50/660; 17 studies), respectively. The rate of an associated extra-CNS anomaly detected on a follow-up ultrasound scan was 2.9% (95% CI, 0.8-6.3%) (19/523; 15 studies), while the rates of those detected exclusively on MRI or on postnatal imaging were 0% (95% CI, 0.0-1.7%) (0/357; 11 studies) and 0.9% (95% CI, 0.3-1.8%) (4/660; 17 studies), respectively. Intrauterine death and perinatal death each occurred in 0.7% (95% CI, 0.3-1.4%) (2/824; 23 studies) of cases. In cases without an associated anomaly detected pre- or postnatally, symptomatic infection was found in 1.5% (95% CI, 0.7-2.7%) (6/548; 19 studies) of infants, the overall rate of a neurodevelopmental anomaly was 3.1% (95% CI, 1.6-5.1%) (16/550; 19 studies), and hearing problems affected 6.5% (95% CI, 3.8-10.0%) (36/550; 19 studies) of children. Subanalyses according to the trimester in which maternal infection occurred were affected by the very small number of included cases and lack of comparison of the observed outcomes in the original studies. Compared with fetuses infected in the second or third trimester, those infected in the first trimester had a relatively higher risk of having an additional anomaly detected on follow-up ultrasound or MRI, abnormal neurodevelopmental outcome and hearing problems. CONCLUSIONS In fetuses with congenital CMV infection in which no anomalies are detected on prenatal ultrasound or MRI, the risk of adverse postnatal outcome is lower than that reported previously in the published literature when not considering the role of antenatal imaging assessment. The results from this review also highlight the potential role of MRI, even in fetuses with no anomalies detected on ultrasound, as an anomaly can be detected exclusively on MRI in about 6% of cases. The findings from this study could enhance prenatal counseling of pregnancies with congenital CMV infection with normal prenatal imaging. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
Collapse
Affiliation(s)
- D Buca
- Centre for High Risk Pregnancy and Fetal Care, Department of Obstetrics and Gynecology, University of Chieti, Italy
| | - D Di Mascio
- Department of Maternal and Child Health and Urological Sciences, "Sapienza" University of Rome, Rome, Italy
| | - G Rizzo
- Division of Maternal and Fetal Medicine, Ospedale Cristo Re, University of Rome Tor Vergata, Rome, Italy
- Department of Obstetrics and Gynecology, The First I.M. Sechenov Moscow State Medical University, Moscow, Russia
| | - A Giancotti
- Department of Maternal and Child Health and Urological Sciences, "Sapienza" University of Rome, Rome, Italy
| | - A D'Amico
- Centre for High Risk Pregnancy and Fetal Care, Department of Obstetrics and Gynecology, University of Chieti, Italy
| | - M Leombroni
- Centre for High Risk Pregnancy and Fetal Care, Department of Obstetrics and Gynecology, University of Chieti, Italy
| | - A Makatsarya
- Department of Obstetrics and Gynecology, The First I.M. Sechenov Moscow State Medical University, Moscow, Russia
| | - A Familiari
- Department of Clinical and Community Sciences, University of Milan, and Department of Woman Child and Neonate, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - M Liberati
- Centre for High Risk Pregnancy and Fetal Care, Department of Obstetrics and Gynecology, University of Chieti, Italy
| | - L Nappi
- Department of Obstetrics and Gynecology, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - M E Flacco
- Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - L Manzoli
- Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - L J Salomon
- Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes and Fetus & LUMIERE team, Paris, France
| | - G Scambia
- Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Fondazione Policlinico A. Gemelli, Rome, Italy
| | - F D'Antonio
- Department of Obstetrics and Gynecology, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| |
Collapse
|
10
|
Giebel S, Sobczyk-Kruszelnicka M, Blamek S, Saduś-Wojciechowska M, Najda J, Czerw T, Mendrek W, Woźniak G, Jochymek B, Radwan M, Leszczyński W, Dolla Ł, D'Amico A, Ślosarek K, Hołowiecki J, Miszczyk L. Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma. Bone Marrow Transplant 2020; 56:1297-1304. [PMID: 33339899 DOI: 10.1038/s41409-020-01181-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Revised: 10/27/2020] [Accepted: 11/27/2020] [Indexed: 01/02/2023]
Abstract
The goal of this phase II trial was to evaluate safety and efficacy of a tandem autologous hematopoietic cell transplantation (auto-HCT) using sequentially total marrow irradiation (TMI) at the dose of 12 Gy (4 Gy on days -3, -2, and -1) and melphalan 200 mg/m2 for patients with multiple myeloma (MM). TMI was performed using helical tomotherapy. Additional "boosts" (total 24 Gy) were applied for patients with active lesions as revealed by PET-FDG. Fifty patients with median age 58 years (41-64 years) were included and received tandem auto-HCT. TMI resulted in absolute neutropenia in all patients. Grade 3 infections were reported in 30% patients. Other toxicities were rare. Proportion of patients who achieved at least very good partial response increased from 46% before the first auto-HCT to 82% after tandem transplantation. Complete remission rates changed from 10% to 42%, respectively. The probabilities of overall and progression-free survival at 5 years were 74% and 55%, respectively. No patient died without progression. We conclude that conditioning with TMI ± PET-guided "boosts" represents personalized treatment approach in MM and is characterized by very good toxicity profile. Tandem auto-HCT using TMI in sequence with high-dose melphalan appears safe with encouraging early efficacy.
Collapse
Affiliation(s)
- Sebastian Giebel
- Department of Bone Marrow Transplantation and Onco-Hematology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
| | - Małgorzata Sobczyk-Kruszelnicka
- Department of Bone Marrow Transplantation and Onco-Hematology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Sławomir Blamek
- Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Maria Saduś-Wojciechowska
- Department of Bone Marrow Transplantation and Onco-Hematology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Jacek Najda
- Department of Bone Marrow Transplantation and Onco-Hematology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Tomasz Czerw
- Department of Bone Marrow Transplantation and Onco-Hematology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Włodzimierz Mendrek
- Department of Bone Marrow Transplantation and Onco-Hematology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Grzegorz Woźniak
- Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Bożena Jochymek
- Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Michał Radwan
- Department of Radiotherapy Planning, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Wojciech Leszczyński
- Department of Radiotherapy Planning, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Łukasz Dolla
- Department of Radiotherapy Planning, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Andrea D'Amico
- Department of PET Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Krzysztof Ślosarek
- Department of Radiotherapy Planning, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Jerzy Hołowiecki
- Department of Bone Marrow Transplantation and Onco-Hematology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| | - Leszek Miszczyk
- Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
| |
Collapse
|
11
|
Di Mascio D, Khalil A, D'Amico A, Buca D, Benedetti Panici P, Flacco ME, Manzoli L, Liberati M, Nappi L, Berghella V, D'Antonio F. Outcome of twin-twin transfusion syndrome according to Quintero stage of disease: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2020; 56:811-820. [PMID: 32330342 DOI: 10.1002/uog.22054] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/25/2019] [Revised: 03/29/2020] [Accepted: 04/12/2020] [Indexed: 06/11/2023]
Abstract
OBJECTIVES To report the outcome of pregnancies complicated by twin-twin transfusion syndrome (TTTS) according to Quintero stage. METHODS MEDLINE, EMBASE and CINAHL databases were searched for studies reporting the outcome of pregnancies complicated by TTTS stratified according to Quintero stage (I-V). The primary outcome was fetal survival rate according to Quintero stage. Secondary outcomes were gestational age at birth, preterm birth (PTB) before 34, 32 and 28 weeks' gestation and neonatal morbidity. Outcomes are reported according to the different management options (expectant management, laser therapy or amnioreduction) for pregnancies with Stage-I TTTS. Only cases treated with laser therapy were considered for those with Stages-II-IV TTTS and only cases managed expectantly were considered for those with Stage-V TTTS. Random-effects head-to-head meta-analysis was used to analyze the extracted data. RESULTS Twenty-six studies (2699 twin pregnancies) were included. Overall, 610 (22.6%) pregnancies were diagnosed with Quintero stage-I TTTS, 692 (25.6%) were Stage II, 1146 (42.5%) were Stage III, 247 (9.2%) were Stage IV and four (0.1%) were Stage V. Survival of at least one twin occurred in 86.9% (95% CI, 84.0-89.7%) (456/552) of pregnancies with Stage-I, in 85% (95% CI, 79.1-90.1%) (514/590) of those with Stage-II, in 81.5% (95% CI, 76.6-86.0%) (875/1040) of those with Stage-III, in 82.8% (95% CI, 73.6-90.4%) (172/205) of those with Stage-IV and in 54.6% (95% CI, 24.8-82.6%) (5/9) of those with Stage-V TTTS. The rate of a pregnancy with no survivor was 11.8% (95% CI, 8.4-15.8%) (69/564) in those with Stage-I, 15.0% (95% CI, 9.9-20.9%) (76/590) in those with Stage-II, 18.6% (95% CI, 14.2-23.4%) (165/1040) in those with Stage-III, 17.2% (95% CI, 9.6-26.4%) (33/205) in those with Stage-IV and in 45.4% (95% CI, 17.4-75.2%) (4/9) in those with Stage-V TTTS. Gestational age at birth was similar in pregnancies with Stages-I-III TTTS, and gradually decreased in those with Stages-IV and -V TTTS. Overall, the incidence of PTB and neonatal morbidity increased as the severity of TTTS increased, but data on these two outcomes were limited by the small sample size of the included studies. When stratifying the analysis of pregnancies with Stage-I TTTS according to the type of intervention, the rate of fetal survival of at least one twin was 84.9% (95% CI, 70.4-95.1%) (94/112) in cases managed expectantly, 86.7% (95% CI, 82.6-90.4%) (249/285) in those undergoing laser therapy and 92.2% (95% CI, 84.2-97.6%) (56/60) in those after amnioreduction, while the rate of double survival was 67.9% (95% CI, 57.0-77.9%) (73/108), 69.7% (95% CI, 61.6-77.1%) (203/285) and 80.8% (95% CI, 62.0-94.2%) (49/60), respectively. CONCLUSIONS Overall survival in monochorionic diamniotic pregnancies affected by TTTS is higher for earlier Quintero stages (I and II), but fetal survival rates are moderately high even in those with Stage-III or -IV TTTS when treated with laser therapy. Gestational age at birth was similar in pregnancies with Stages-I-III TTTS, and gradually decreased in those with Stages-IV and -V TTTS treated with laser and expectant management, respectively. In pregnancies affected by Stage-I TTTS, amnioreduction was associated with slightly higher survival compared with laser therapy and expectant management, although these findings may be confirmed only by future head-to-head randomized trials. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.
Collapse
Affiliation(s)
- D Di Mascio
- Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA
| | - A Khalil
- Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, University of London, London, UK
- Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK
| | - A D'Amico
- Department of Obstetrics and Gynecology, University of Chieti, Chieti, Italy
| | - D Buca
- Department of Obstetrics and Gynecology, University of Chieti, Chieti, Italy
| | - P Benedetti Panici
- Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy
| | - M E Flacco
- Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - L Manzoli
- Department of Medical Sciences, University of Ferrara, Ferrara, Italy
| | - M Liberati
- Department of Obstetrics and Gynecology, University of Chieti, Chieti, Italy
| | - L Nappi
- Fetal Medicine and Cardiology Unit, Department of Obstetrics and Gynecology, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - V Berghella
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA
| | - F D'Antonio
- Fetal Medicine and Cardiology Unit, Department of Obstetrics and Gynecology, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| |
Collapse
|
12
|
Geraldo AF, Messina SS, Tortora D, Parodi A, Malova M, Morana G, Gandolfo C, D'Amico A, Herkert E, Govaert P, Ramenghi LA, Rossi A, Severino M. Neonatal Developmental Venous Anomalies: Clinicoradiologic Characterization and Follow-Up. AJNR Am J Neuroradiol 2020; 41:2370-2376. [PMID: 33093132 DOI: 10.3174/ajnr.a6829] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Accepted: 08/06/2020] [Indexed: 11/07/2022]
Abstract
BACKGROUND AND PURPOSE Although developmental venous anomalies have been frequently studied in adults and occasionally in children, data regarding these entities are scarce in neonates. We aimed to characterize clinical and neuroimaging features of neonatal developmental venous anomalies and to evaluate any association between MR imaging abnormalities in their drainage territory and corresponding angioarchitectural features. MATERIALS AND METHODS We reviewed parenchymal abnormalities and angioarchitectural features of 41 neonates with developmental venous anomalies (20 males; mean corrected age, 39.9 weeks) selected through a radiology report text search from 2135 neonates who underwent brain MR imaging between 2008 and 2019. Fetal and longitudinal MR images were also reviewed. Neurologic outcomes were collected. Statistics were performed using χ2, Fisher exact, Mann-Whitney U, or t tests corrected for multiple comparisons. RESULTS Developmental venous anomalies were detected in 1.9% of neonatal scans. These were complicated by parenchymal/ventricular abnormalities in 15/41 cases (36.6%), improving at last follow-up in 8/10 (80%), with normal neurologic outcome in 9/14 (64.2%). Multiple collectors (P = .008) and larger collector caliber (P < .001) were significantly more frequent in complicated developmental venous anomalies. At a patient level, multiplicity (P = .002) was significantly associated with the presence of ≥1 complicated developmental venous anomaly. Retrospective fetal detection was possible in 3/11 subjects (27.2%). CONCLUSIONS One-third of neonatal developmental venous anomalies may be complicated by parenchymal abnormalities, especially with multiple and larger collectors. Neuroimaging and neurologic outcomes were favorable in most cases, suggesting a benign, self-limited nature of these vascular anomalies. A congenital origin could be confirmed in one-quarter of cases with available fetal MR imaging.
Collapse
Affiliation(s)
- A F Geraldo
- From the Neuroradiology Unit (A.F.G.), Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.,Neuroradiology Unit (A.F.G., D.T., G.M., A.R., M.S.)
| | - S S Messina
- Radiology Unit (S.S.M.), Casa di Cura Regina Pacis, Palermo, Italy
| | - D Tortora
- Neuroradiology Unit (A.F.G., D.T., G.M., A.R., M.S.)
| | - A Parodi
- Neonatal Intensive Care Unit (A.P., M.M., L.A.R.)
| | - M Malova
- Neonatal Intensive Care Unit (A.P., M.M., L.A.R.)
| | - G Morana
- Neuroradiology Unit (A.F.G., D.T., G.M., A.R., M.S.)
| | - C Gandolfo
- Interventional Unit (C.G.), IRCCS Istituto Giannina Gaslini, Genova, Italy
| | - A D'Amico
- Dipartimento di Scienze Biomediche Avanzate (A.D.), Universita' Federico II, Napoli, Italy
| | - E Herkert
- Division of Neonatology (E.H., P.G.), Department of Paediatrics, Erasmus University Medical Centre, Rotterdam, the Netherlands
| | - P Govaert
- Division of Neonatology (E.H., P.G.), Department of Paediatrics, Erasmus University Medical Centre, Rotterdam, the Netherlands
| | - L A Ramenghi
- Neonatal Intensive Care Unit (A.P., M.M., L.A.R.)
| | - A Rossi
- Neuroradiology Unit (A.F.G., D.T., G.M., A.R., M.S.)
| | - M Severino
- Neuroradiology Unit (A.F.G., D.T., G.M., A.R., M.S.)
| |
Collapse
|
13
|
Comellas LC, Sánchez-Montañez Á, Maggi L, Díaz-Manera J, Pichiecchio A, D'Amico A, Monforte M, Brisca G, Løkken N, Marini-Bettolo C, Vlodavets D, Walter M, Straub V, Quijano-Roy S, Yves-Carlier R, Vissing J, Mercuri E, Bertini E, Gómez-Andrés D, Munell F, Tasca G. MUSCLE IMAGING – MRI. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
14
|
Muni-Lofra R, Coratti G, Ramsey D, Moat D, Sodhi J, James M, D'Amico A, Scoto M, Pane M, Bertini E, Marini-Bettolo C, Muntoni F, Mercuri E, Mayhew A. SMA - CLINICAL. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
15
|
Appolloni L, D'Amico A, Raffo M, Capasso L. Hygienic and sanitary standards of housing in Europe: a comparative analysis of nine countries. Ann Ig 2020; 32:52-65. [PMID: 33146367 DOI: 10.7416/ai.2020.3394] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
In recent years, growing interest was devoted to housing conditions from both scientific community and public health, so they are now considered among the main environmental and social health determinants of health of the population. Aim of the study is to analyze and compare the current regulations regarding housing sanitary requirements in different Countries of the EU (Sweden, United Kingdom, Denmark, the Netherlands, France, Germany, Portugal, Spain) with the contents of the Italian Health Ministerial Decree 5th July 1975. From the websites of the official channels of the various countries the regulations have been downloaded. For the comparison, only the aspects of BCs concerning the scale of the building were examined; the comparison concerned all the requirements of the Health Ministerial Decree of 5.07.1975 and some other parameters (e.g. indoor chemical pollution, ionizing radiation, non-ionizing radiation) not provided for in the Ministerial Decree, treated in the other standards regulations, and relevant for the indoor well-being of the occupants. The authors observe a wide variability in the contents and in the formulation of the hygienic-sanitary requirements among the different Building Codes, above all as regards the dimensional data and some fundamental themes (e.g. heating systems, mechanical ventilation) whose treatment is often not it is updated with respect to the technological-scientific innovation consolidated over the past few years. A diverse approach among European Countries is also observed: from a market-oriented logic (e.g. UK), to a prescriptive one (Italy), to a functionality-oriented (the Netherlands). The comparative analysis we carried out made it possible to identify convergences and divergences in the standards analysed for the different European countries. As far as the Italian legislation on the usability of residential premises, finally, considering the health, social, environmental and economic trends, many standards contained in the MD 5th July 1975 should be reviewed and updated.
Collapse
Affiliation(s)
- L Appolloni
- Department of Civil, Building, Environmental Engineering, Sapienza University of Rome, Italy
| | - A D'Amico
- Department of Civil, Building, Environmental Engineering, Sapienza University of Rome, Italy
| | - M Raffo
- Public Health Unit, Department of Prevention (SISP), Local Health Trust 1 (ASL RM 1), Rome, Italy
| | - L Capasso
- Italian Ministry of Instruction, University and Research, Abruzzo Regional School Office, Chieti, Italy
| |
Collapse
|
16
|
Adorisio R, Cantarutti N, D'Amico A, Bertini E, Catteruccia M, Perri G, D'Amario D, Filippelli S, Drago F, Amodeo A. Long-Term Outcome of LVAD in Duchenne Population with End Stage Cardiomyopathy. J Heart Lung Transplant 2020. [DOI: 10.1016/j.healun.2020.01.857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
17
|
Kubeczko M, D'Amico A, Polakiewicz-Gilowska A, Badora-Rybicka A, Borys D, Gorczewska I, Pietro MD, Chrabański O, Bal W, Michalik A, Raus M, Pasierbek A, Tarnawski R, Bobek-Billewicz B, Jarząb M. Abstract P4-02-12: Association of nodal stage as assessed by FDG PET/CT with pathological complete response rate after preoperative chemotherapy. Cancer Res 2020. [DOI: 10.1158/1538-7445.sabcs19-p4-02-12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Preoperative chemotherapy (preopCT) is gaining importance in management of breast cancer, as it allows to avoid axillary clearance in responders. In case of axillary surgery the pathological complete response (pCR) of involved nodes is required to omit lymphadenectomy. Selecting the patients (pts) for axillary-sparing surgery is a challenging task, as currently it is reserved for N1 stage, but no more detailed criteria exist.
FDG-PET/CT is a valuable tool to assess the extent of systemic disease in breast cancer before chemotherapy, used in stage III and selected stage IIB patients. The axillary nodal burden assessed in PET/CT could potentially affect the chances of pCR, and thus influence the decisions whether to clip the involved LNs and whether to proceed with either SNB or primary lymphadenectomy.
The aim of the study was to assess the sensitivity of PET/CT to diagnose involved axillary LNs and to verify whether FDG-PET/CT axillary staging is associated with the rate of pathological complete response after preopCT.
Material and Methods. The study group consisted of 287 pts with breast cancer with regional lymph node involvement, treated by preopCT, within the prospective trial analyzing the clinical and molecular predictors of response to preopCT, upon the approval of Ethics Committee at our Institution and after patients’ informed consent. Among them 16 (5.6%) had cT1 tumor, 131 (45.6%) T2, 69 (24.0%) T3 and 66 (23.0%) T4. Clinical nodal stage was N1 in 164 pts (57.1%), 94 (32.8%) had N2 and 29 (10.5%) N3 disease. 24 tumors were grade 1 (8.7%), 83 tumors grade 2 (30.1%) and the majority - 157 of tumors (56.9%) - grade 3. There were 81 pts (28.2%) with HER2-positive subtypes, 151 pts with luminal HER2-negative subtypes (52.6%) and 55 pts with TNBC (19.1%). 260 pts (90.6%) showed sufficient tumor regression to undergo surgery.
Results. In 55 pts we observed pCR (21.6%), in 205 pts (78.9%) no pCR was found. When the regional lymph nodes were assessed by PET/CT pre-chemotherapy (data obtained in 259 pts, 90.2%), in 42 patients (16.2%) no uptake was found (despite positive thin-needle biopsy), in 65 pts (25.1%) there was uptake in single lymph node (LN), in 47 pts (18.1%) in two LN, and in 105 (40.5%) uptake was found in three or more LNs - thus, the vast majority (86%) exhibited uptake on PET/CT. Median of maximal SUV in lymph nodes was 4.9 (IQR 2.1-9.8), median of SUV in breast was 7.6 (IQR 4.4-12.0). In 160 patients (70.8%) SUVmax in LNs was lower than in breast (ratio<1), in 66 patients (29.2%) SUVmax in LNs was higher than in breast. Median of breast/axilla SUVmax ratio was 71.4% (IQR 38.1%-110.1%).
pCR rate did not depend on regional nodal burden: in patients with cN1 disease, pCR rate was 21.8%, in cN2 19.8% and in cN3 22.2% (non-significant, n.s.). When number of nodes, as assessed by FDG PET was taken into account, pCR rate in pts with no uptake in LNs was 17,5%, in pts with uptake in 1-2 LNs pCR rate was 20.9% and in pts with 3 and more LNs pCR rate was 20.7% (n.s.). When the ratio of tumor/nodes SUVmax was analyzed, no difference in pCR rate between pts with ratio below 1 (22.2%) and above >=1 (16.4%; n.s.) was found.
However, pCR rate was associated with biological tumor features: higher in G3 tumors, TNBC and HER2 subtypes, as well as in tumors with small diameter (data not shown).
Conclusions. Patients with higher burden of regional lymph node involvement exhibit equal chance of pathological complete response as compared to low-volume/low-uptake individuals. The feasibility of limited surgery in higher stage regional nodal disease with pCR after chemotherapy shall be tested in prospective trials.
The study was supported by the Polish National Center of Research and Development MILESTONE project - Molecular diagnostics and imaging in individualized therapy for breast, thyroid and prostate cancer, grant no. STRATEGMED 2/267398/4/NCBR/2015.
Citation Format: Marcin Kubeczko, Andrea D'Amico, Anna Polakiewicz-Gilowska, Agnieszka Badora-Rybicka, Damian Borys, Izabela Gorczewska, Marco Di Pietro, Olgierd Chrabański, Wiesław Bal, Anna Michalik, Mateusz Raus, Agnieszka Pasierbek, Rafał Tarnawski, Barbara Bobek-Billewicz, Michał Jarząb. Association of nodal stage as assessed by FDG PET/CT with pathological complete response rate after preoperative chemotherapy [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P4-02-12.
Collapse
Affiliation(s)
- Marcin Kubeczko
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Andrea D'Amico
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Anna Polakiewicz-Gilowska
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Agnieszka Badora-Rybicka
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Damian Borys
- 2Silesian University of Technology Gliwice, Gliwice, Poland
| | - Izabela Gorczewska
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Marco Di Pietro
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Olgierd Chrabański
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Wiesław Bal
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Anna Michalik
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Mateusz Raus
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Agnieszka Pasierbek
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Rafał Tarnawski
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Barbara Bobek-Billewicz
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| | - Michał Jarząb
- 1Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland, Gliwice, Poland
| |
Collapse
|
18
|
Signoriello E, D'Amico A, Fratta M, Ugga L, Altobelli C, Conchiglia G, Barbarulo AM, Di Pietro A, Anastasio P, Rossi F, Lus G. Alemtuzumab significantly improves posterior fossa syndrome presented as a relapse of multiple sclerosis. Mult Scler Relat Disord 2019; 38:101518. [PMID: 31778927 DOI: 10.1016/j.msard.2019.101518] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2019] [Revised: 11/07/2019] [Accepted: 11/10/2019] [Indexed: 11/30/2022]
Abstract
BACKGROUND Posterior fossa syndrome (PFS) is a rare manifestation of ponto-mesencephalic lesions frequently reported in post-surgical pediatric tumors, rarely described as a consequence of vascular, infective or inflammatory lesions. OBJECTIVE The aim of this article is to report the clinical and neuroradiological characteristics of a patient with an acute PFS presentation as a relapse in relapsing-remitting MS, significantly responsive to Alemtuzumab treatment. CASE REPORT 24-year-old patient affected by multiple sclerosis developed motor-cognitive and behavioral syndrome related to an extensive ponto-mesencephalic lesion under Fingolimod treatment. CONCLUSION Our case highlights the significant and rapid effect of Alemtuzumab therapy on both cognitive and motor symptoms occurring during a MS relapse with atypical neuroradiological localization.
Collapse
Affiliation(s)
- E Signoriello
- Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy.
| | - A D'Amico
- Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy
| | - M Fratta
- Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy
| | - L Ugga
- Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy
| | - C Altobelli
- Unit of Nephrology, Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
| | - G Conchiglia
- Alma Mater, Villa Camaldoli Hospital, Naples, Italy
| | - A M Barbarulo
- Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy
| | - A Di Pietro
- Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy
| | - P Anastasio
- Unit of Nephrology, Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy
| | - F Rossi
- Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy
| | - G Lus
- Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy
| |
Collapse
|
19
|
Maggi L, Verardo M, Rubegni A, Bruno C, Lupica A, Berardinelli A, Ripolone M, Vattemi G, Ruggiero L, D'Amico A, Rodolico C, Sciacco M, Nigro V, Santorelli F, Tonin P, Fiorillo C, Mora M. P.110Clinical, morphological and genetic data in Italian patients with fiber-type-disproportion. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
20
|
Adorisio R, D'Amario D, Cantarutti N, Cicenia M, D'Amico A, Baban A, Bertini E, Catteruccia M, Perri G, Filippelli S, Drago F, Amodeo A. P3446Left-ventricular assist device as a destination therapy in Duchenne cardiomyopathy: are we ready to change the natural history? Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0319] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Heart failure is becoming the most prominent cause of death among patients with Duchenne Muscular Dystrophy (DMD) and end-stage cardiomyopathy (CMP). Implantation of left ventricular assist devices (LVAD) as destination therapy (DT) in this group of patients is still matter of debate. No current data are available on long-term follow- up of young patients.
Purpose
The aim of this study was to evaluate the long-term outcome of LVAD in DMD end stage heart failure (HF) compared to a group treated optimal medical treatment (OMT) with inotropes
Methods
All patients affected by DMD patients presenting with end-stage HF receiving OMT or LVAD have been reviewed. All data about characteristics of HF at presentation including assessment of nutritional status and respiratory function, left ventricular ejection fraction, brain natriuretic peptide, serum sodium, in-hospital treatment and long term follow up have been collected. OMT group was constituted by 4 patients matching implantation VAD criteria but not eligible or refusing treatment. Survival was represented by Kaplan Meier analysis.
Results
A total of 12 DMD patients with end-stage CMP were considered for this analysis. 8 have been implanted with LVAD during the period from 2011 until mid-2017 and compared with 4 treated with OMT. Mean systolic pressure was 103 versus 91 mmHg in those not receiving LVAD (p=0.2), and left ventricular ejection fraction at the time of presentation was 16‰ for LVAD group and 22‰ for the second group (p=0.1). LVADs improved survival throughout follow-up for patients undergoing baseline inotropic infusions (P=0.0014); for the LVAD group versus the OMT group, 1-month survival was 100‰ and 67‰ respectively and 2-month survival was 100‰ versus 0‰. For LVAD group survival was 86‰ at one year, 71‰ at 2 years and 48‰ at 5 years from implantation. Analysis on short and long-term follow-up showed significant improvement of survival in DMD patients treated with LVAD (log rank<0.001), with a 5-year increase in life expectancy.
Conclusions
LVAD improved outcomes in patients with LVAD when compared to those without. Long-term follow-up was similar to DT LVAD adult population. Further studies are necessary to confirm these data.
Collapse
Affiliation(s)
- R Adorisio
- Bambino Gesù Children's Hospital and Research Institute, Department of Pediatric Cardiology and Cardiac Surgery, Rome, Italy
| | - D D'Amario
- Catholic University of the Sacred Heart, Rome, Italy
| | - N Cantarutti
- Bambino Gesù Children's Hospital and Research Institute, Department of Pediatric Cardiology and Cardiac Surgery, Rome, Italy
| | - M Cicenia
- Bambino Gesù Children's Hospital and Research Institute, Department of Pediatric Cardiology and Cardiac Surgery, Rome, Italy
| | - A D'Amico
- Bambino Gesù Children's Hospital and Research Institute, Department of Pediatric Cardiology and Cardiac Surgery, Rome, Italy
| | - A Baban
- Bambino Gesù Children's Hospital and Research Institute, Department of Pediatric Cardiology and Cardiac Surgery, Rome, Italy
| | - E Bertini
- Bambino Gesù Children's Hospital and Research Institute, Department of Pediatric Cardiology and Cardiac Surgery, Rome, Italy
| | - M Catteruccia
- Bambino Gesù Children's Hospital and Research Institute, Department of Pediatric Cardiology and Cardiac Surgery, Rome, Italy
| | - G Perri
- Bambino Gesù Children's Hospital and Research Institute, Department of Pediatric Cardiology and Cardiac Surgery, Rome, Italy
| | - S Filippelli
- Bambino Gesù Children's Hospital and Research Institute, Department of Pediatric Cardiology and Cardiac Surgery, Rome, Italy
| | - F Drago
- Bambino Gesù Children's Hospital and Research Institute, Department of Pediatric Cardiology and Cardiac Surgery, Rome, Italy
| | - A Amodeo
- Bambino Gesù Children's Hospital and Research Institute, Department of Pediatric Cardiology and Cardiac Surgery, Rome, Italy
| |
Collapse
|
21
|
Bello L, D'Angelo G, Bruno C, Berardinelli A, Comi G, D'Amico A, Astrea G, Politano L, Baranello G, Sansone V, Previtali S, Vita G, Mongini T, Pini A, Mercuri E, Calore C, Vianello A, Hoffman E, McDonald C, Pegoraro E. P.267Modifiers of respiratory and cardiac function in the Italian Duchenne muscular dystrophy network and CINRG Duchenne natural history study. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.381] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
22
|
Rossi R, Trabanelli C, Falzarano M, Sabatelli P, Grilli A, Bicciato S, D'Amico A, Ferlini A, Gualandi F. P.386Genome and transcriptome analysis of COLVI genes and characterization of a new promising cellular model. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
23
|
D'Amico A, Montagna MT, Caggiano G, De Giglio O, Rutigliano S, Lopuzzo M, Mascipinto S, Napoli C, Currà E, D'Alessandro D. Observational study on hospital building heritage and microbiological air quality in the orthopedic operating theater: the IM.PA.C.T. Project. Ann Ig 2019; 31:482-495. [PMID: 31304528 DOI: 10.7416/ai.2019.2309] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
BACKGROUND The study investigated 35 orthopedic OTs [17 with mixed flow (M-OTs), 18 with turbulent flow (T-OTs)]. METHODS The OTs were divided into two categories based on recurring architectural and construction solutions, collected by a survey form: type-A (recently built or renovated rooms), and type-B (other OTs). Assessment of microbial air contamination (colony forming units (cfu)/m3 obtained by active sampling via Surface Air System) was then performed. RESULTS In 97% of the OTs, a Total Viable Count (TVC) was within the limits recommended by ISPESL 2009; all A-type OTs, and 94% of B-type passed. The TVC of type-A OTs [median 15 cfu/m3, range 3-158] was lower than that of type-B OTs [median 28 cfu/m3, range 6-206], although the difference was not significant. The number of people in type-A [mean 8.6, range 6-11] was lower than in type-B [mean 9.6, range 7-13] OTs, and when adjusted to the volume of the OT (person/m3), showed a significant correlation with TVC (ρ = 0.383, p <0.05). CONCLUSIONS In conclusion, the structural factors examined do not appear to significantly affect the microbiological air quality at the specific sampling point. However, further investigations are required to identify the factors that have the greatest effect on TVC.
Collapse
Affiliation(s)
- A D'Amico
- Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy - Department of Civil, Building and Environmental Engineering, "Sapienza" University of Rome, Rome, Italy
| | - M T Montagna
- Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy
| | - G Caggiano
- Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy
| | - O De Giglio
- Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy
| | - S Rutigliano
- Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy
| | - M Lopuzzo
- Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy
| | - S Mascipinto
- Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy
| | - C Napoli
- Department of Medical and Surgical Sciences and Translational Medicine, "Sapienza" University of Rome, Rome, Italy
| | - E Currà
- Department of Civil, Building and Environmental Engineering, "Sapienza" University of Rome, Rome, Italy
| | - D D'Alessandro
- Department of Civil, Building and Environmental Engineering, "Sapienza" University of Rome, Rome, Italy
| |
Collapse
|
24
|
D'Amico A, Ugga L, Cuocolo R, Cirillo M, Grandone A, Conforti R. Persisting Embryonal Infundibular Recess in Morning Glory Syndrome: Clinical Report of a Novel Association. AJNR Am J Neuroradiol 2019; 40:899-902. [PMID: 30846438 DOI: 10.3174/ajnr.a6005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2018] [Accepted: 01/14/2019] [Indexed: 11/07/2022]
Abstract
Morning glory syndrome is characterized by a congenital optic disc defect that resembles the eponymous flower. We present the MR imaging findings of 2 pediatric patients with morning glory disc anomaly and persisting embryonal infundibular recess, another rare malformative finding, a previously unreported association. Neuroradiologists should be aware of the possible presence of a persisting embryonal infundibular recess in patients with morning glory syndrome, to aid in the differential diagnosis including other pituitary malformations such as pituitary stalk duplication.
Collapse
Affiliation(s)
- A D'Amico
- From the Department of Advanced Biomedical Sciences (A.D., L.U., R. Cuocolo), University of Naples "Federico II," Naples, Italy
| | - L Ugga
- From the Department of Advanced Biomedical Sciences (A.D., L.U., R. Cuocolo), University of Naples "Federico II," Naples, Italy
| | - R Cuocolo
- From the Department of Advanced Biomedical Sciences (A.D., L.U., R. Cuocolo), University of Naples "Federico II," Naples, Italy
| | - M Cirillo
- Dipartimento di Scienze Mediche, Chirurgiche, Neurologiche (M.C.)
| | - A Grandone
- Metaboliche e dell'Invecchiamento, Dipartimento della Donna (A.G.), del Bambino e di Chirurgia Generale e Specialistica
| | - R Conforti
- Dipartimento di Medicina di Precisione (R. Conforti), University of Campania "Luigi Vanvitelli," Naples, Italy
| |
Collapse
|
25
|
Bertini E, Verrigni D, Battaglia D, Torraco A, Figa Talamanca L, Carrozzo R, Diodato D, D'Amico A, Papetti L, Ghezzi D, Ardissone A, Lamperti C, Legati A, Goffrini P. MITOCHONDRIAL DISEASES (Posters). Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
26
|
D'Amico A, Fattori F, Fiorillo C, Verardo M, Catteruccia M, Bellacchio E, Moggio M, Bruno C, Bertini E. CONGENITAL MYOPATHIES: NEMALINE AND TITINOPATHIES. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
27
|
Peretto G, Di Resta C, Perversi J, Forleo C, Maggi L, Previtali S, Politano L, Manzi RC, D'Amico A, Limongelli G, Ambrosi A, Ferrari M, Della Bella P, Sala S, Benedetti S. P3170Innovative approach for risk stratification of LMNA-related cardiomyopathy: results from an integrated cardiological and neurological 10-year follow-up multicentre study. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- G Peretto
- San Raffaele Hospital of Milan (IRCCS), Department of Arrhythmology and Cardiac Electrophysiology, Milan, Italy
| | - C Di Resta
- San Raffaele Hospital of Milan (IRCCS), Laboratory of Molecular Biology and Cytogenetics, Milan, Italy
| | - J Perversi
- University of Turin, Department of Cardiology, Turin, Italy
| | - C Forleo
- Polyclinic Hospital of Bari, Department of Cardiology, Bari, Italy
| | - L Maggi
- IRCCS Neurologic Institute Besta, Neurology, Milan, Italy
| | - S Previtali
- San Raffaele Hospital of Milan (IRCCS), Department of Neurology, Milan, Italy
| | - L Politano
- Second University of Naples, Department of Cardiology, Naples, Italy
| | - R C Manzi
- University of Cagliari, Department of Cardiology, Cagliari, Italy
| | - A D'Amico
- Bambino Gesu Childrens Hospital, Department of Cardiology, Rome, Italy
| | - G Limongelli
- AO dei Colli-Monaldi Hospital, Department of Cardiology, Naples, Italy
| | - A Ambrosi
- San Raffaele Hospital of Milan (IRCCS), Department of Biostatistics, Milan, Italy
| | - M Ferrari
- San Raffaele Hospital of Milan (IRCCS), Laboratory of Molecular Biology and Cytogenetics, Milan, Italy
| | - P Della Bella
- San Raffaele Hospital of Milan (IRCCS), Department of Arrhythmology and Cardiac Electrophysiology, Milan, Italy
| | - S Sala
- San Raffaele Hospital of Milan (IRCCS), Department of Arrhythmology and Cardiac Electrophysiology, Milan, Italy
| | - S Benedetti
- San Raffaele Hospital of Milan (IRCCS), Laboratory of Molecular Biology and Cytogenetics, Milan, Italy
| | | |
Collapse
|
28
|
Sansone VA, Pane M, Messina S, Bruno C, D'Amico A, Albamonte E, Catteruccia M, Sframeli M, Pedemonte M, Vita G, Bertini E, Mercuri E. A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript "single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1" written by pechmann and colleagues". Eur J Paediatr Neurol 2018; 22:729-731. [PMID: 29673809 DOI: 10.1016/j.ejpn.2018.02.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/08/2018] [Accepted: 02/12/2018] [Indexed: 11/17/2022]
Affiliation(s)
- V A Sansone
- Neurorehabilitation Unit, University of Milan, The NEMO (NEuroMuscular Omniservice) Clinical Center, Milan, Italy.
| | - M Pane
- The NEMO Clinical Center and Dept of Child Neurology, University Gemelli Hospital, Rome, Italy
| | - S Messina
- The NEMO Clinical Center and Dept of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - C Bruno
- Center of Myology, Istituto Giannina Gaslini, Genoa, Italy
| | - A D'Amico
- Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, Rome, Italy
| | - E Albamonte
- Neurorehabilitation Unit, University of Milan, The NEMO (NEuroMuscular Omniservice) Clinical Center, Milan, Italy
| | - M Catteruccia
- Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, Rome, Italy
| | - M Sframeli
- The NEMO Clinical Center and Dept of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - M Pedemonte
- Center of Myology, Istituto Giannina Gaslini, Genoa, Italy
| | - G Vita
- The NEMO Clinical Center and Dept of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - E Bertini
- Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, Rome, Italy
| | - E Mercuri
- The NEMO Clinical Center and Dept of Child Neurology, University Gemelli Hospital, Rome, Italy
| |
Collapse
|
29
|
Fattori F, Fiorillo C, Rodolico C, Tasca G, Verardo M, Bellacchio E, Pizzi S, Ciolfi A, Fagiolari G, Lupica A, Broda P, Pedemonte M, Moggio M, Bruno C, Tartaglia M, Bertini E, D'Amico A. Expanding the histopathological spectrum of CFL2
-related myopathies. Clin Genet 2018; 93:1234-1239. [DOI: 10.1111/cge.13240] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2017] [Revised: 02/13/2018] [Accepted: 02/14/2018] [Indexed: 11/29/2022]
Affiliation(s)
- F. Fattori
- Unit of Neuromuscular and Neurodegenerative Disorders, Genetics and Rare Diseases Research Division; Bambino Gesù Children's Hospital; Rome Italy
| | - C. Fiorillo
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics; Maternal and Child Health, University of Genoa; Genoa Italy
| | - C. Rodolico
- Department of Clinical and Experimental Medicine; University of Messina; Messina Italy
| | - G. Tasca
- Istituto di Neurologia; Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario "A. Gemelli"; Rome Italy
| | - M. Verardo
- Unit of Neuromuscular and Neurodegenerative Disorders, Genetics and Rare Diseases Research Division; Bambino Gesù Children's Hospital; Rome Italy
| | - E. Bellacchio
- Molecular Genetics and Functional Genomics, Genetics and Rare Diseases Research Division; Bambino Gesù Children's Hospital; Rome Italy
| | - S. Pizzi
- Molecular Genetics and Functional Genomics, Genetics and Rare Diseases Research Division; Bambino Gesù Children's Hospital; Rome Italy
| | - A. Ciolfi
- Molecular Genetics and Functional Genomics, Genetics and Rare Diseases Research Division; Bambino Gesù Children's Hospital; Rome Italy
| | - G. Fagiolari
- Neuromuscular and Rare Disease Unit, Department of Neuroscience, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico; University of Milan; Milan Italy
| | - A. Lupica
- Department of Clinical and Experimental Medicine; University of Messina; Messina Italy
| | - P. Broda
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics; Maternal and Child Health, University of Genoa; Genoa Italy
| | - M. Pedemonte
- Center of Myology and Neurodegenerative Disease; Istituto Giannina Gaslini; Genova Italy
| | - M. Moggio
- Neuromuscular and Rare Disease Unit, Department of Neuroscience, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico; University of Milan; Milan Italy
| | - C. Bruno
- Center of Myology and Neurodegenerative Disease; Istituto Giannina Gaslini; Genova Italy
| | - M. Tartaglia
- Molecular Genetics and Functional Genomics, Genetics and Rare Diseases Research Division; Bambino Gesù Children's Hospital; Rome Italy
| | - E. Bertini
- Unit of Neuromuscular and Neurodegenerative Disorders, Genetics and Rare Diseases Research Division; Bambino Gesù Children's Hospital; Rome Italy
- Molecular Genetics and Functional Genomics, Genetics and Rare Diseases Research Division; Bambino Gesù Children's Hospital; Rome Italy
| | - A. D'Amico
- Unit of Neuromuscular and Neurodegenerative Disorders, Genetics and Rare Diseases Research Division; Bambino Gesù Children's Hospital; Rome Italy
| |
Collapse
|
30
|
Annoussamy M, Lilien C, Gidaro T, Gargaun E, Chê V, Schara U, D'Amico A, Daron A, Cuisset J, Mayer M, Hernandez A, Vuillerot C, Fontaine S, de Lattre C, Bellance R, Biancalana V, Buj-Bello A, Hogrel J, Landy H, Servais L. Longitudinal data of patients with myotubular myopathy enrolled in a European prospective and longitudinal natural history study. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
31
|
Catteruccia M, Colia G, Bonetti A, Carlesi A, Oggiano L, La Rosa G, Turturro F, Bertini E, Bertini E, D'Amico A. Scoliosis is an inescapable comorbidity in SMA type II. A single center experience. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.153] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
32
|
Viola S, Grammauta R, Sciacca V, Bellia G, Beranzoli L, Buscaino G, Caruso F, Chierici F, Cuttone G, D'Amico A, De Luca V, Embriaco D, Favali P, Giovanetti G, Marinaro G, Mazzola S, Filiciotto F, Pavan G, Pellegrino C, Pulvirenti S, Simeone F, Speziale F, Riccobene G. Continuous monitoring of noise levels in the Gulf of Catania (Ionian Sea). Study of correlation with ship traffic. Mar Pollut Bull 2017; 121:97-103. [PMID: 28559054 DOI: 10.1016/j.marpolbul.2017.05.040] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/03/2017] [Revised: 05/16/2017] [Accepted: 05/16/2017] [Indexed: 05/24/2023]
Abstract
Acoustic noise levels were measured in the Gulf of Catania (Ionian Sea) from July 2012 to May 2013 by a low frequency (<1000Hz) hydrophone, installed on board the NEMO-SN1 multidisciplinary observatory. NEMO-SN1 is a cabled node of EMSO-ERIC, which was deployed at a water depth of 2100m, 25km off Catania. The study area is characterized by the proximity of mid-size harbors and shipping lanes. Measured noise levels were correlated with the passage of ships tracked with a dedicated AIS antenna. Noise power was measured in the frequency range between 10Hz and 1000Hz. Experimental data were compared with the results of a fast numerical model based on AIS data to evaluate the contribution of shipping noise in six consecutive 1/3 octave frequency bands, including the 1/3 octave frequency bands centered at 63Hz and 125Hz, indicated by the Marine Strategy Framework Directive (2008/56/EC).
Collapse
Affiliation(s)
- S Viola
- Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Via S. Sofia, 62, Catania 95123, Italy.
| | - R Grammauta
- Istituto per l'Ambiente Marino Costiero U.O.S. di Capo Granitola-Consiglio Nazionale delle Ricerche (IAMC-CNR), Via del Mare 3, Granitola 91021, Trapani, Italy
| | - V Sciacca
- Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Via S. Sofia, 62, Catania 95123, Italy; Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali, University of Messina, Viale F. Stagno D'Alcontres, 31, Messina 98166, Italy; Consorzio Nazionale Interuniversitario per le Scienze del Mare (CoNISMa), Piazzale Flaminio 9, 00196 Roma, Italy
| | - G Bellia
- Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Via S. Sofia, 62, Catania 95123, Italy; Consorzio Nazionale Interuniversitario per le Scienze del Mare (CoNISMa), Piazzale Flaminio 9, 00196 Roma, Italy; Dipartimento di Fisica e Astronomia, University of Catania, via Santa Sofia 64, 95123 Catania, Italy
| | - L Beranzoli
- Istituto Nazionale di Geofisica e Vulcanologia (INGV) - Via di Vigna Murata 605, 00143 Roma, Italy
| | - G Buscaino
- Istituto per l'Ambiente Marino Costiero U.O.S. di Capo Granitola-Consiglio Nazionale delle Ricerche (IAMC-CNR), Via del Mare 3, Granitola 91021, Trapani, Italy
| | - F Caruso
- Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Via S. Sofia, 62, Catania 95123, Italy; Istituto per l'Ambiente Marino Costiero U.O.S. di Capo Granitola-Consiglio Nazionale delle Ricerche (IAMC-CNR), Via del Mare 3, Granitola 91021, Trapani, Italy
| | - F Chierici
- Istituto Nazionale di Geofisica e Vulcanologia (INGV) - Via di Vigna Murata 605, 00143 Roma, Italy; Istituto di Scienze Marine - Consiglio Nazionale delle Ricerche (ISMAR-CNR), Via Gobetti 101, 40129 Bologna, Italy; Istituto di Radioastronomia - Istituto Nazionale di Astrofisica (IRA-INAF), Via Gobetti, 101, 40129 Bologna, Italy
| | - G Cuttone
- Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Via S. Sofia, 62, Catania 95123, Italy
| | - A D'Amico
- NIKHEF, Science Park 105 1098 XG, Amsterdam, The Netherlands
| | - V De Luca
- Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Via S. Sofia, 62, Catania 95123, Italy
| | - D Embriaco
- Istituto Nazionale di Geofisica e Vulcanologia (INGV) - Via di Vigna Murata 605, 00143 Roma, Italy
| | - P Favali
- Istituto Nazionale di Geofisica e Vulcanologia (INGV) - Via di Vigna Murata 605, 00143 Roma, Italy
| | - G Giovanetti
- Istituto Nazionale di Geofisica e Vulcanologia (INGV) - Via di Vigna Murata 605, 00143 Roma, Italy; Agenzia nazionale per le nuove tecnologie, l'energia e lo sviluppo economico sostenibile (ENEA), via Enrico Fermi 45, 00044 Frascati, Roma, Italy
| | - G Marinaro
- Istituto Nazionale di Geofisica e Vulcanologia (INGV) - Via di Vigna Murata 605, 00143 Roma, Italy
| | - S Mazzola
- Istituto per l'Ambiente Marino Costiero U.O.S. di Capo Granitola-Consiglio Nazionale delle Ricerche (IAMC-CNR), Via del Mare 3, Granitola 91021, Trapani, Italy
| | - F Filiciotto
- Istituto per l' Ambiente Marino Costiero U.O. di Messina - Consiglio Nazionale delle Ricerche (IAMC-CNR), Spianata S. Raineri 86, 98122 Messina, Italy
| | - G Pavan
- Consorzio Nazionale Interuniversitario per le Scienze del Mare (CoNISMa), Piazzale Flaminio 9, 00196 Roma, Italy; Centro Interdisciplinare di Bioacustica e Ricerche Ambientali (CIBRA), Dipartimento di Scienze della Terra e dell'Ambiente, University of Pavia, Via Taramelli 24, 27100 Pavia, Italy
| | - C Pellegrino
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Bologna, Viale Berti Pichat, 6/2, 40127 Bologna, Italy; Dipartimento di Fisica e Astronomia, University of Bologna, Viale Berti Pichat, 6/2, 40127 Bologna, Italy
| | - S Pulvirenti
- Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Via S. Sofia, 62, Catania 95123, Italy
| | - F Simeone
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, P.le Aldo Moro, 2,00185 Roma, Italy
| | - F Speziale
- Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Via S. Sofia, 62, Catania 95123, Italy
| | - G Riccobene
- Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali del Sud (INFN-LNS), Via S. Sofia, 62, Catania 95123, Italy
| |
Collapse
|
33
|
Fontana P, Melis D, D'Amico A, Cappuccio G, Auletta G, Vassallo P, Genesio R, Nitsch L, Buffolano W. Sensorineural Hearing Loss in a Patient Affected by Congenital Cytomegalovirus Infection: Is It Useful to Identify Comorbid Pathologies? J Pediatr Genet 2017; 6:181-185. [PMID: 28794912 DOI: 10.1055/s-0037-1599223] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2016] [Accepted: 01/26/2017] [Indexed: 10/20/2022]
Abstract
Sensorineural hearing loss (SNHL) is a common defect with a multifactorial etiology. Congenital cytomegalovirus infection (cCMV) is the most common infectious cause, and its early detection allows a prompt pharmacological treatment that can improve hearing prognosis. In a consistent percentage of profound SNHL, genetic causes and/or inner ear malformations are involved; their prompt diagnosis might change therapeutic options. This study reports a case of a 3- year-old female patient with symptomatic cCMV infection who also exhibits developmental delay, dysmorphic facial features, bilateral hearing loss, and cochlear incomplete partition, type 2, in 7q21.3 deletion. This deletion includes the genes DLX5 and DLX6 , which could be the candidate genes for the ear malformation named incomplete partition, type 2.
Collapse
Affiliation(s)
- P Fontana
- Department of Molecular Medicine and Medical Biotechnologies, "Federico II" University of Naples, Naples, Italy
| | - D Melis
- Section of Pediatrics, Department of Translational Medical Sciences, "Federico II" University of Naples, Naples, Italy
| | - A D'Amico
- Section of Diagnostic Imaging, Department of Advanced Biomedical Sciences, "Federico II" University of Naples, Naples, Italy
| | - G Cappuccio
- Section of Pediatrics, Department of Translational Medical Sciences, "Federico II" University of Naples, Naples, Italy
| | - G Auletta
- Department of Neurosciences, "Federico II" University of Naples, Naples, Italy
| | - P Vassallo
- Department of Ophthalmology, "Federico II" University of Naples, Naples, Italy
| | - R Genesio
- Department of Molecular Medicine and Medical Biotechnologies, "Federico II" University of Naples, Naples, Italy
| | - L Nitsch
- Department of Molecular Medicine and Medical Biotechnologies, "Federico II" University of Naples, Naples, Italy
| | - W Buffolano
- Section of Pediatrics, Department of Translational Medical Sciences, "Federico II" University of Naples, Naples, Italy
| |
Collapse
|
34
|
Adorisio R, Cantarutti N, D'Amico A, Chinali M, Baban A, Iorio F, Amodeo A, Drago F. P5275Heart rate reduction strategy with ivabradine is effective in reducing acute heart failure in duchenne dilated cardiomyopathy. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p5275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
35
|
Verrigni D, Diodato D, Di Nottia M, Torraco A, Bellacchio E, Rizza T, Tozzi G, Verardo M, Piemonte F, Tasca G, D'Amico A, Bertini E, Carrozzo R. Novel mutations in KARS cause hypertrophic cardiomyopathy and combined mitochondrial respiratory chain defect. Clin Genet 2017; 91:918-923. [PMID: 27891585 DOI: 10.1111/cge.12931] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2016] [Revised: 11/21/2016] [Accepted: 11/23/2016] [Indexed: 11/26/2022]
Abstract
Mutations in KARS, which encodes for both mitochondrial and cytoplasmic lysyl-tRNA synthetase, have been so far associated with three different phenotypes: the recessive form of Charcot-Mary-Tooth polyneuropathy, the autosomal recessive nonsyndromic hearing loss and the last recently described condition related to congenital visual impairment and progressive microcephaly. Here we report the case of a 14-year-old girl with severe cardiomyopathy associated to mild psychomotor delay and mild myopathy; moreover, a diffuse reduction of cytochrome C oxidase (COX, complex IV) and a combined enzymatic defect of complex I (CI) and complex IV (CIV) was evident in muscle biopsy. Using the TruSight One sequencing panel we identified two novel mutations in KARS. Both mutations, never reported previously, occur in a highly conserved region of the catalytic domain and displayed a dramatic effect on KARS stability. Structural analysis confirmed the pathogenic role of the identified variants. Our findings confirm and emphasize that mt-aminoacyl-tRNA synthetases (mt-ARSs) enzymes are related to a broad clinical spectrum due to their multiple and still unknown functions.
Collapse
Affiliation(s)
- D Verrigni
- Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Rome, Italy
| | - D Diodato
- Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Rome, Italy
| | - M Di Nottia
- Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Rome, Italy
| | - A Torraco
- Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Rome, Italy
| | - E Bellacchio
- Research Laboratories, 'Bambino Gesù' Children's Hospital, IRCCS, Rome, Italy
| | - T Rizza
- Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Rome, Italy
| | - G Tozzi
- Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Rome, Italy
| | - M Verardo
- Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Rome, Italy
| | - F Piemonte
- Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Rome, Italy
| | - G Tasca
- Institute of Neurology, Policlinico 'A. Gemelli' Foundation University Hospital, Rome, Italy
| | - A D'Amico
- Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Rome, Italy
| | - E Bertini
- Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Rome, Italy
| | - R Carrozzo
- Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Rome, Italy
| |
Collapse
|
36
|
Ragusa R, Cabiati M, Guzzardi MA, D'Amico A, Giannessi D, Del Ry S, Caselli C. Effects of obesity on IL-33/ST2 system in heart, adipose tissue and liver: study in the experimental model of Zucker rats. Exp Mol Pathol 2017; 102:354-359. [PMID: 28274612 DOI: 10.1016/j.yexmp.2017.03.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2016] [Revised: 02/24/2017] [Accepted: 03/01/2017] [Indexed: 01/15/2023]
Abstract
Suppression of tumorigenicity 2 (ST2) mediates the effect of Interleukin-33 (IL-33). Few data are reported on the relationship between IL-33/ST2 and obesity. We aimed to investigate effects of obesity on IL-33/ST2 system in heart, adipose tissue and liver in a rodent model of obesity. The relationship of cardiac expression of IL-33/ST2 system with natriuretic peptides (NPs) system and inflammatory mediators was also studied. mRNA expression of IL-33/ST2 system was evaluated in cardiac, adipose and hepatic biopsies from obese Zucker rats (O) and controls (CO). Expression levels of sST2 was significantly lower in O rats compared with CO (p<0.05) in all tissues. Besides, the mRNA levels of IL-33 decreased significant in fat of O respect to CO, while, expression levels of ST2L was significantly higher in liver of CO than in O. A strong relationship of IL-33/ST2 with NPs and classical inflammatory mediators was observed in cardiac tissue. Expression of sST2 in cardiac, adipose and liver tissue decreased in O compared with controls, suggesting an involvement for IL-33/ST2 system in molecular mechanisms of obesity. The strong relationships with NP systems and inflammatory mediators could suggest an involvement for IL-33/ST2 in molecular pathways leading to cardiac dysfunction and inflammation associated with obesity.
Collapse
Affiliation(s)
| | | | | | - Andrea D'Amico
- Scuola Superiore Sant'Anna, Pisa, Pisa, Italy; Harvard Department of Stem Cell and Regenerative Biology, Cambridge, MA, USA
| | | | - Silvia Del Ry
- Institute of Clinical Physiology of CNR, Pisa, Italy
| | | |
Collapse
|
37
|
Abstract
We studied five patients with gelastic epilepsy sustained by hamartoma of the tuber cinereum, submitted to EEG and Video-EEG study and to MR examination. The mechanism of ictal laughter, clinical associations and prognosis for seizure control are discussed. Hamartomas should be always suspected when gelastic seizures occur, and appropriate diagnostic tools should be employed for their diagnosis. In patients presenting with gelastic epilepsy, MR assessment of the hypothalamic region is necessary to identify a hamartoma of the tuber cinereum. Moreover, the resolution of MR imaging provides a basis to correlate some of the clinical manifestations with the anatomical disposition of the lesion within the hypothalamus. Gelastic epilepsy seems to correlate with large broad-based hamartomas in relationship with the mamillary bodies. In these cases, surgical treatment should be considered when symptoms are not sufficiently responsive to medical therapy.
Collapse
Affiliation(s)
| | | | | | | | - S. Striano
- Department of Neurological Sciences, “Federico II” University School of Medicine, Napoli
| | | |
Collapse
|
38
|
Neri M, Scotton C, Gualandi F, Wirth B, Schols L, Klockgether T, Lochmuller H, Muntoni F, D'Amico A, Bertini E, Pane M, Mercuri E, Ferlini A. Genetic landscapes in neuromuscular disorders: The influence of next-generation sequencing analysis. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
39
|
Maggi L, Lo Monaco M, Portaro S, Meola G, Desaphy J, Lucchiari S, Pagliarani S, Bernasconi P, Imbrici P, Comi G, Mantegazza R, Trojano M, D'Amico A, Pegoraro E, Politano L, Mongini T, Siciliano G, Conte Camerino D, Toscano A, Sansone V. Prevalence study of muscle channelopathies in Italy. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.400] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
40
|
Bonanni L, Di Giacomo R, D'Amico A, Frazzini V, Franciotti R, Manzoli L, Thomas A, Onofrj M. Akinetic crisis in dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2016; 87:1123-6. [PMID: 27068351 DOI: 10.1136/jnnp-2015-312914] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2015] [Accepted: 03/22/2016] [Indexed: 11/03/2022]
Abstract
BACKGROUND AND PURPOSE Dementia with Lewy bodies (DLB) is characterised by neuroleptic hypersensitivity. It is unclear, however, whether the neuroleptic hypersensitivity implies an increased incidence of neuroleptic malignant syndrome (NMS) or of akinetic crisis (AC), which are expressions of the same possibly lethal clinical event, and whether AC in DLB can appear independently of neuroleptic treatment. In our prospective study, we assessed the incidence of AC in a cohort of DLB as compared with that in patients with Parkinson disease (PD). METHODS In total, 614 patients with PD and 236 DLB were recruited and followed during 2005-2013. AC was diagnosed as sudden akinetic state unresponsive to dopaminergic rescue drugs, dysphagia and serological alterations without recovery for 48 h or more requiring hospital admission. Exposure to neuroleptics was specifically evaluated, because of the high implicit risk in DLB. RESULTS 24 patients with PD (3.9%) and 16 patients with DLB (6.8%) developed AC. 77 (32.6%) DLB and 32 (5.2%) PD were exposed to typical neuroleptics, but only 8 DLB and 3 PD presented with AC. Disease duration before AC was lower in DLB than in PD group (p<0.01). Outcome was fatal in 8 patients with (50%) DLB and 3 (12.5%) PD (p=0.05). When age and use of neuroleptics were adjusted for into a Cox proportional hazards model predicting time to AC, the HR of patients with DLB was 13.0 (95% CI 4.23 to 39.9; p<0.001). CONCLUSIONS AC in DLB can appear independently of neuroleptic treatment, occurs earlier and is more frequently fatal than in PD.
Collapse
Affiliation(s)
- L Bonanni
- Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy
| | - R Di Giacomo
- Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy
| | - A D'Amico
- Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy
| | - V Frazzini
- Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy
| | - R Franciotti
- Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy
| | - L Manzoli
- Section of Epidemiology, Department of Medicine and Aging, University G d'Annunzio of Chieti-Pescara, Chieti, Italy Regional Healthcare Agency of Abruzzo, Abruzzo, Italy
| | - A Thomas
- Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy
| | - M Onofrj
- Department of Neuroscience Imaging and Clinical Sciences and CESI, University G d'Annunzio of Chieti-Pescara, Chieti, Italy
| |
Collapse
|
41
|
Fiacco E, Castagnetti F, Bianconi V, Madaro L, De Bardi M, Nazio F, D'Amico A, Bertini E, Cecconi F, Puri PL, Latella L. Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles. Cell Death Differ 2016; 23:1839-1849. [PMID: 27447110 DOI: 10.1038/cdd.2016.70] [Citation(s) in RCA: 91] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2015] [Revised: 05/16/2016] [Accepted: 06/13/2016] [Indexed: 12/21/2022] Open
Abstract
Autophagy is emerging as a key regulatory process during skeletal muscle development, regeneration and homeostasis, and deregulated autophagy has been implicated in muscular disorders and age-related muscle decline. We have monitored autophagy in muscles of mdx mice and human Duchenne muscular dystrophy (DMD) patients at different stages of disease. Our data show that autophagy is activated during the early, compensatory regenerative stages of DMD. A progressive reduction was observed during mdx disease progression, in coincidence with the functional exhaustion of satellite cell-mediated regeneration and accumulation of fibrosis. Moreover, pharmacological manipulation of autophagy can influence disease progression in mdx mice. Of note, studies performed in regenerating muscles of wild-type mice revealed an essential role of autophagy in the activation of satellite cells upon muscle injury. These results support the notion that regeneration-associated autophagy contributes to the early compensatory stage of DMD progression, and interventions that extend activation of autophagy might be beneficial in the treatment of DMD. Thus, autophagy could be a 'disease modifier' targeted by interventions aimed to promote regeneration and delay disease progression in DMD.
Collapse
Affiliation(s)
- E Fiacco
- Laboratory of Epigenetic and Regenerative Pharmacology, IRCCS Fondazione Santa Lucia, Rome, Italy.,Department of Medicine, Institute of Translational Pharmacology, National Research Council of Italy, Rome, Italy
| | - F Castagnetti
- Laboratory of Epigenetic and Regenerative Pharmacology, IRCCS Fondazione Santa Lucia, Rome, Italy.,Department of Medicine, Institute of Translational Pharmacology, National Research Council of Italy, Rome, Italy
| | - V Bianconi
- Laboratory of Epigenetic and Regenerative Pharmacology, IRCCS Fondazione Santa Lucia, Rome, Italy
| | - L Madaro
- Laboratory of Epigenetic and Regenerative Pharmacology, IRCCS Fondazione Santa Lucia, Rome, Italy.,Department of Life Sciences, Cell Biology and Neurobiology Institute, National Research Council of Italy, Roma, Italy
| | - M De Bardi
- Laboratory of Epigenetic and Regenerative Pharmacology, IRCCS Fondazione Santa Lucia, Rome, Italy
| | - F Nazio
- Department of Biology, University of Rome Tor Vergata, Rome, Italy.,Department of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
| | - A D'Amico
- Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, Rome, Italy
| | - E Bertini
- Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, Rome, Italy
| | - F Cecconi
- Department of Biology, University of Rome Tor Vergata, Rome, Italy.,Unit of Cell Stress and Survival, Danish Cancer Society Research Center, Copenhagen, Denmark
| | - P L Puri
- Laboratory of Epigenetic and Regenerative Pharmacology, IRCCS Fondazione Santa Lucia, Rome, Italy.,Muscle Development and Regeneration Program, Sanford Children's Health Research Center, Sanford Prebys Burnham Medical Discovery Institute, La Jolla, CA 92037, USA
| | - L Latella
- Laboratory of Epigenetic and Regenerative Pharmacology, IRCCS Fondazione Santa Lucia, Rome, Italy.,Department of Medicine, Institute of Translational Pharmacology, National Research Council of Italy, Rome, Italy
| |
Collapse
|
42
|
Fiorillo C, Astrea G, Savarese M, Cassandrini D, Brisca G, Trucco F, Pedemonte M, Trovato R, Ruggiero L, Vercelli L, D'Amico A, Tasca G, Pane M, Fanin M, Bello L, Broda P, Musumeci O, Rodolico C, Messina S, Vita GL, Sframeli M, Gibertini S, Morandi L, Mora M, Maggi L, Petrucci A, Massa R, Grandis M, Toscano A, Pegoraro E, Mercuri E, Bertini E, Mongini T, Santoro L, Nigro V, Minetti C, Santorelli FM, Bruno C. MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients. Orphanet J Rare Dis 2016; 11:91. [PMID: 27387980 PMCID: PMC4936326 DOI: 10.1186/s13023-016-0476-1] [Citation(s) in RCA: 52] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2016] [Accepted: 06/22/2016] [Indexed: 01/27/2023] Open
Abstract
BACKGROUND Myosin heavy chain 7 (MYH7)-related myopathies are emerging as an important group of muscle diseases of childhood and adulthood, with variable clinical and histopathological expression depending on the type and location of the mutation. Mutations in the head and neck domains are a well-established cause of hypertrophic cardiomyopathy whereas mutation in the distal regions have been associated with a range of skeletal myopathies with or without cardiac involvement, including Laing distal myopathy and Myosin storage myopathy. Recently the spectrum of clinical phenotypes associated with mutations in MYH7 has increased, blurring this scheme and adding further phenotypes to the list. A broader disease spectrum could lead to misdiagnosis of different congenital myopathies, neurogenic atrophy and other neuromuscular conditions. RESULTS As a result of a multicenter Italian study we collected clinical, histopathological and imaging data from a population of 21 cases from 15 families, carrying reported or novel mutations in MYH7. Patients displayed a variable phenotype including atypical pictures, as dropped head and bent spine, which cannot be classified in previously described groups. Half of the patients showed congenital or early infantile weakness with predominant distal weakness. Conversely, patients with later onset present prevalent proximal weakness. Seven patients were also affected by cardiomyopathy mostly in the form of non-compacted left ventricle. Muscle biopsy was consistent with minicores myopathy in numerous cases. Muscle MRI was meaningful in delineating a shared pattern of selective involvement of tibialis anterior muscles, with relative sparing of quadriceps. CONCLUSION This work adds to the genotype-phenotype correlation of MYH7-relatedmyopathies confirming the complexity of the disorder.
Collapse
Affiliation(s)
- C Fiorillo
- IRCCS Stella Maris, Molecular Medicine and Neuromuscular Disorders, Via dei Giacinti 2, 56128, Calambrone, Pisa, Italy. .,Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternad and Child Health, University of Genova, University of Genoa, Genoa, Italy.
| | - G Astrea
- IRCCS Stella Maris, Molecular Medicine and Neuromuscular Disorders, Via dei Giacinti 2, 56128, Calambrone, Pisa, Italy
| | - M Savarese
- Telethon Institute of Genetics and Medicine, Naples, Italy
| | - D Cassandrini
- IRCCS Stella Maris, Molecular Medicine and Neuromuscular Disorders, Via dei Giacinti 2, 56128, Calambrone, Pisa, Italy
| | - G Brisca
- Unit of Pediatric Neurology and Muscular Disorders, Istituto G.Gaslini, Genoa, Italy.,Department of Neuroscience, Center of Myology and Neurodegenerative Disorders, Istituto Giannina Gaslini, Genoa, Italy
| | - F Trucco
- Unit of Pediatric Neurology and Muscular Disorders, Istituto G.Gaslini, Genoa, Italy
| | - M Pedemonte
- Unit of Pediatric Neurology and Muscular Disorders, Istituto G.Gaslini, Genoa, Italy
| | - R Trovato
- IRCCS Stella Maris, Molecular Medicine and Neuromuscular Disorders, Via dei Giacinti 2, 56128, Calambrone, Pisa, Italy
| | - L Ruggiero
- Department of Neurosciences and Reproductive and Odontostomatologic Sciences, University Federico II, Naples, Italy
| | - L Vercelli
- Department of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy
| | - A D'Amico
- Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
| | - G Tasca
- Don Carlo Gnocchi ONLUS Foundation, Rome, Italy
| | - M Pane
- Department of Paediatric Neurology, Catholic University, Rome, Italy
| | - M Fanin
- Department of Neurosciences, University of Padua, Padua, Italy
| | - L Bello
- Department of Neurosciences, University of Padua, Padua, Italy
| | - P Broda
- Unit of Pediatric Neurology and Muscular Disorders, Istituto G.Gaslini, Genoa, Italy
| | - O Musumeci
- Department of Clinical and Experimental Medicine and Nemo Sud Clinical Centre, University of Messina, Messina, Italy
| | - C Rodolico
- Department of Clinical and Experimental Medicine and Nemo Sud Clinical Centre, University of Messina, Messina, Italy
| | - S Messina
- Department of Clinical and Experimental Medicine and Nemo Sud Clinical Centre, University of Messina, Messina, Italy
| | - G L Vita
- Department of Clinical and Experimental Medicine and Nemo Sud Clinical Centre, University of Messina, Messina, Italy
| | - M Sframeli
- Department of Clinical and Experimental Medicine and Nemo Sud Clinical Centre, University of Messina, Messina, Italy
| | - S Gibertini
- Neuromuscular Diseases and Neuroimmunology Unit, IRCCS Foundation C Besta Neurological Institute, Milan, Italy
| | - L Morandi
- Neuromuscular Diseases and Neuroimmunology Unit, IRCCS Foundation C Besta Neurological Institute, Milan, Italy
| | - M Mora
- Neuromuscular Diseases and Neuroimmunology Unit, IRCCS Foundation C Besta Neurological Institute, Milan, Italy
| | - L Maggi
- Neuromuscular Diseases and Neuroimmunology Unit, IRCCS Foundation C Besta Neurological Institute, Milan, Italy
| | - A Petrucci
- Center for Neuromuscular and Neurological Rare Diseases, S. Camillo-Forlanini Hospital, Rome, Italy
| | - R Massa
- Department of Systems Medicine (Neurology), University of Tor Vergata, Rome, Italy
| | - M Grandis
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternad and Child Health, University of Genova, University of Genoa, Genoa, Italy
| | - A Toscano
- Department of Clinical and Experimental Medicine and Nemo Sud Clinical Centre, University of Messina, Messina, Italy
| | - E Pegoraro
- Department of Neurosciences, University of Padua, Padua, Italy
| | - E Mercuri
- Department of Paediatric Neurology, Catholic University, Rome, Italy
| | - E Bertini
- Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
| | - T Mongini
- Department of Neurosciences "Rita Levi Montalcini", University of Turin, Turin, Italy
| | - L Santoro
- Department of Neurosciences and Reproductive and Odontostomatologic Sciences, University Federico II, Naples, Italy
| | - V Nigro
- Telethon Institute of Genetics and Medicine, Naples, Italy
| | - C Minetti
- Unit of Pediatric Neurology and Muscular Disorders, Istituto G.Gaslini, Genoa, Italy.,Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternad and Child Health, University of Genova, University of Genoa, Genoa, Italy
| | - F M Santorelli
- IRCCS Stella Maris, Molecular Medicine and Neuromuscular Disorders, Via dei Giacinti 2, 56128, Calambrone, Pisa, Italy
| | - C Bruno
- Department of Neuroscience, Center of Myology and Neurodegenerative Disorders, Istituto Giannina Gaslini, Genoa, Italy
| | | |
Collapse
|
43
|
Belz J, Kumar R, Makrigiorgos G, D'Amico A, Nguyen P, Cormack R, Sridhar S. WE-FG-BRA-02: Docetaxel Eluting Brachytherapy Spacers for Local Chemo-Radiation Therapy in Prostate Cancer. Med Phys 2016. [DOI: 10.1118/1.4957902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
44
|
Grzbiela H, Tarnawski R, D'Amico A, Stąpór-Fudzińska M. The Use of 68Ga-DOTA-(Tyr3)-Octreotate PET/CT for Improved Target Definition in Radiotherapy Treatment Planning of Meningiomas - A Case Report. Curr Radiopharm 2016; 8:45-8. [PMID: 25808961 DOI: 10.2174/1874471008666150316222923] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2014] [Revised: 02/06/2015] [Accepted: 03/13/2015] [Indexed: 11/22/2022]
Abstract
Due to somatostatin receptor expression in meningiomas, PET with somatostatin analogs appears to be useful in radiotherapy treatment planning. We report the case of a 63-year-old man diagnosed with meningioma of the left frontal lobe in 2011. He underwent total tumor excision (pathology was atypical meningioma WHO 2) and radiotherapy, but one year after the completion of treatment, he complained about diplopia and left upper eyelid ptosis. The MRI showed a new parasagittal lesion and the patient received stereotactic radiotherapy. Few weeks later, two new lesions were found - one in the sella turcica region and the other adjacent to the greater wing of the right sphenoid bone. The patient underwent transsphenoidal biopsy, but was not qualified for neurosurgery due to high risk of bleeding. In the radiotherapy treatment planning, we used a fusion of MRI and 68Ga-DOTA-(Tyr3)-octreotate PET/CT images. The patient received stereotactic radiotherapy, first to the parasellar lesion and then to the progressing tumor adjoining the sphenoid bone. In both cases, PET/CT scans helped to define the target, its volume being bigger on PET/CT than on MRI images. In patients with meningiomas, 68-Ga-DOTA-(Tyr3)-octreotate PET/CT can be considered as a useful imaging modality in radiotherapy treatment planning, which helps to visualize the tumor extension and to define the target.
Collapse
Affiliation(s)
- Hanna Grzbiela
- Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Poland.
| | | | | | | |
Collapse
|
45
|
Pulvirenti S, Ameli F, D'Amico A, Kieft G, Schmelling JW. Characterization of the electro-optical transceivers in the KM3NeT optical network. EPJ Web of Conferences 2016. [DOI: 10.1051/epjconf/201611605006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
46
|
Distefano C, Aiello S, Ameli F, Anghinolfi M, Barbarino G, Barbarito E, Barbato F, Beverini N, Biagi S, Bouhadef B, Bozza C, Cacopardo G, Calamai M, Calì C, Capone A, Caruso F, Ceres A, Chiarusi T, Circella M, Cocimano R, Coniglione R, Costa M, Cuttone G, D'Amato C, D'Amico A, Bonis GD, Luca VD, Deniskina N, Rosa GD, Capua FD, Fermani P, Flaminio V, Fusco L, Garufi F, Giordano V, Gmerk A, Grasso R, Grella G, Hugon C, Imbesi M, Kulikovskiy V, Larosa G, Lattuada D, Leismueller K, Leonora E, Litrico P, Lonardo A, Longhitano F, Presti DL, Maccioni E, Margiotta A, Martini A, Masullo R, Migliozzi P, Migneco E, Miraglia A, Mollo C, Mongelli M, Morganti M, Musico P, Musumeci M, Nicolau C, Orlando A, Papaleo R, Pellegrino C, Pellegriti M, Perrina C, Piattelli P, Pugliatti C, Pulvirenti S, Orselli A, Raffaelli F, Randazzo N, Riccobene G, Rovelli A, Sanguineti M, Sapienza P, Sciacca V, Sgura I, Simeone F, Sipala V, Speziale F, Spina M, Spitaleri A, Spurio M, Stellacci S, Taiuti M, Terreni G, Trasatti L, Trovato A, Ventura C, Vicini P, Viola S, Vivolo AD. Measurement of the atmospheric muon flux at 3500 m depth with the NEMO Phase-2 detector. EPJ Web of Conferences 2016. [DOI: 10.1051/epjconf/201612105015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
47
|
Ragusa R, Cabiati M, Iozzo P, D'Amico A, Del Ry S, Caselli C. Cardiac alterations of IL33/ST2 system in the Zucker rat model of obesity: Relationship with natriuretic peptide system and inflammatory mediators. Vascul Pharmacol 2015. [DOI: 10.1016/j.vph.2015.11.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
48
|
Ragusa R, Prontera C, Di Molfetta A, Cabiati M, D'Amico A, Storti S, Cantinotti M, Federico G, Del Ry S, Amodeo A, Clerico A, Trivella M, Caselli C. Biohumoral profile of pediatric patients with heart failure submitted to ventricular assist device support. Vascul Pharmacol 2015. [DOI: 10.1016/j.vph.2015.11.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
49
|
Fiorillo C, Savarese M, Astrea G, Cassandrini D, Ruggiero L, Fanin M, Vercelli L, D'Amico A, Pane M, Tasca G, Morandi M, Pegoraro E, Santoro L, Mercuri E, Mora M, Bertini E, Minetti C, Santorelli F, Nigro V, Bruno C. MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
50
|
Bertini E, Sferra A, Rizza T, Tasca G, D'Amico A, Zanni G, Barresi S, Diodato D, Piermarini E, Martinelli D, Dionisi-Vici C, Niceta M, Dallapiccola B, Tartaglia M, Compagnucci C. Distal spinal muscular atrophy and ataxia with cerebellar atrophy in two unrelated patients; a new phenotypic variant of HRD and recessive KCS syndrome related to TBCE. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|